Aethlon Medical, Inc. (OTCMKTS:AEMD) issued its earnings results on Thursday. The medical equipment provider reported ($0.14) EPS for the quarter, beating analysts’ consensus estimates of ($0.16) by $0.02, Bloomberg Earnings reports.

Separately, ValuEngine cut Aethlon Medical from a “sell” rating to a “strong sell” rating in a research report on Wednesday, October 11th.

TRADEMARK VIOLATION WARNING: This report was published by American Banking News and is the property of of American Banking News. If you are accessing this report on another publication, it was stolen and republished in violation of international copyright & trademark laws. The original version of this report can be viewed at https://www.americanbankingnews.com/2017/11/03/aethlon-medical-inc-aemd-releases-earnings-results-beats-estimates-by-0-02-eps.html.

Aethlon Medical Company Profile

Aethlon Medical, Inc is a medical device company focused on creating devices for cancer, infectious disease and other life-threatening conditions. The Company operates through two segments: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities.

Earnings History for Aethlon Medical (OTCMKTS:AEMD)

Receive News & Ratings for Aethlon Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.